|
Evaluation of phosphorylated tau protein as a core biomarker of Alzheimer's disease
H Hampel, Ludwig-Maximilian-University, Munich, Germany
|
|
The use of biomarkers in the CSF for diagnosis of early alzheimer disease and mild cognitive impairment
Niels Andreasen, Neurotec, Karolinska Institute, Sweden
|
|
Clinical applications of biomarkers in Alzheimer's disease: From CSF to imaging amyloid
Hiroyuki Arai, Advanced Research Center for Asian Traditional Medicine, Tohoku University, Japan
|
|
Diagnosis of dementia and mental health strategy for the elderly
Masatoshi Takeda, Osaka University Graduate School of Medicine, Japan
|
|
How well to CSF tau and β-amyloid levels predict a patient's autopsy confirmed dementia diagnosis
Christopher M Clark, University of Pennsylvania, United States
|